{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:34:07Z","timestamp":1792524847645,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006625.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,11,18]],"date-time":"2013-11-18T00:00:00Z","timestamp":1384732800000}}],"reference-count":348,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006625.pub3","type":"journal-article","created":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T01:40:21Z","timestamp":1384825221000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Quetiapine versus other atypical antipsychotics for schizophrenia"],"prefix":"10.1002","volume":"2013","author":[{"given":"Laila","family":"Asmal","sequence":"first","affiliation":[{"name":"University of Stellenbosch; Department of Psychiatry; Faculty of Medicine and Health Sciences PO Box 19063 Tygerberg South Africa 7505"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srnka J","family":"Flegar","sequence":"additional","affiliation":[{"name":"University of Stellenbosch; Department of Psychiatry; Faculty of Medicine and Health Sciences PO Box 19063 Tygerberg South Africa 7505"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jikun","family":"Wang","sequence":"additional","affiliation":[{"name":"East China Normal University; School of Psychology and Cognitive Science; 3663 North Zhongshan Road Shanghai China 200062"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rummel-Kluge","sequence":"additional","affiliation":[{"name":"University of Leipzig; Clinic and Outpatient Clinic of Psychiatry and Psychotherapy; Semmelweisstrasse 10 Leipzig Saxony Germany 04103"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Komossa","sequence":"additional","affiliation":[{"name":"University Hospital of Zurich; Department of Psychiatry and Psychotherapy; Culmannstrasse 8 Zurich Switzerland CH-8091"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; Ismaningerstrasse 22 M\u00fcnchen Germany 81675"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,11,18]]},"reference":[{"key":"10.1002\/14651858.CD006625.pub3-BIB0001|cit1","unstructured":"Astrazeneca 1998 A multicentre, double-blind randomised comparison of seroquel (TM) and risperidone in the treatment of schizophrenic patients with acute exacerbation Astrazeneca trial data"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4088\/JCP.v64n0516","article-title":"Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics","volume":"64","author":"Atmaca","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.psychres.2007.02.014","article-title":"Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial","volume":"159","author":"Byerly","year":"2008","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0004|cit4","doi-asserted-by":"crossref","unstructured":"Canuso C Carothers J Dirks B Zhu Y Kosik-Gonzalez C A double-blind, placebo-controlled trial of paliperidone ER and quetiapine in patients with a recent acute exacerbation of schizophrenia Proceedings of the American Psychiatric Association 161st Annual Meeting, Washington, DC, May 3-6, 2008","DOI":"10.1016\/S0920-9964(08)70760-6"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.schres.2007.12.372","article-title":"A comparative analysis of paliperidone ER and quetiapine in patients with a recent, acute exacerbation of schizophrenia","volume":"98","author":"Canuso","year":"2008","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0006|cit6","doi-asserted-by":"crossref","unstructured":"Canuso C Dirks B Carothers J Zhu Y Kosik-Gonzalez C A double-blind, placebo controlled trial of paliperidone ER and quetiapine in patients with a recent acute exacerbation of schizophrenia Proceedings of the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders, Montreux, Switzerland, February 3-7, 2007","DOI":"10.1016\/S0920-9964(08)70760-6"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0007|cit7","unstructured":"Canuso C Dirks B Carothers J Zhu Y Kosik-Gonzalez C A double-blind, placebo-controlled trial of paliperidone ER and quetiapine in patients with a recent acute exacerbation of schizophrenia Proceedings of the 20th Annual U.S. Psychiatric & Mental Health Congress, Orlando, FL, October 11-14, 2007"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0008|cit8","first-page":"1","article-title":"Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia","volume":"AiA","author":"Canuso","year":"2009","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/01.wnf.0000172993.89879.0f","article-title":"Risperidone, quetiapine, and fluphenazine in the treatment of patients with therapy-refractory schizophrenia","volume":"28","author":"Conley","year":"2005","journal-title":"Clinical Neuropharmacology"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.psyneuen.2005.08.010","article-title":"A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia","volume":"31","author":"Kelly","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4088\/JCP.v66n0111","article-title":"Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine","volume":"66","author":"Kelly","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0012|cit12","first-page":"501","article-title":"Risperidone vs quetiapine vs fluphenazine in treatment-resistant schizophrenia: neuropsychological outcome","volume":"31","author":"Richardson","year":"2005","journal-title":"Schizophrenia Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0013|cit13","first-page":"713\u201320","article-title":"Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder","volume":"4","author":"Deberdt","year":"2008","journal-title":"Therapeutics and Clinical Risk Management"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0014|cit14","doi-asserted-by":"crossref","unstructured":"Eerdekens M Kramer M Cleton A Vanderbosch A Natarajan J Earnest J Proceedings of the 20th European College of Neuropsychopharmacology, Vienna, Austria, October 13-17, 2007","DOI":"10.1016\/S0924-977X(07)70714-9"},{"issue":"0","key":"10.1002\/14651858.CD006625.pub3-BIB0015|cit15","first-page":"1","article-title":"Evaluation of the effect of paliperidone extended release and quetiapine on corrected QT intervals: a randomized, double-blind, placebo-controlled study","volume":"0","author":"Hough","year":"2010","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.schres.2009.05.030","article-title":"Effectiveness of second-generation antipsychotics with acute-phase schizophrenia","volume":"113","author":"Hatta","year":"2009","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0017|cit17","first-page":"16","article-title":"A comparative study between quetiapine and risperidone in the treatment of first-episode schizophrenia","volume":"25","author":"Hu","year":"2008","journal-title":"Chinese Medical Journal of Metallurgical Industry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0018|cit18","unstructured":"Kinon BJ Liu-Siefert H Hill AL Roychowdhury S Edwards SB Superiority of olanzapine versus quetiapine in improving overall functioning in patients with schizophrenia Proceedings of the 16th European College of Neuropsychopharmacology Congress, September 20-24, 2003"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/01.jcp.0000236658.16286.25","article-title":"Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning","volume":"26","author":"Kinon","year":"2006","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0020|cit20","first-page":"219","article-title":"A study of quetiapine and clozapine in treatment of first-episode schizophrenia","volume":"28","author":"Li","year":"2002","journal-title":"Chinese Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0021|cit21","first-page":"306","article-title":"A study of quetiapine and clozapine in treatment of schizophrenia","volume":"29","author":"Li","year":"2003","journal-title":"Chinese Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0022|cit22","first-page":"262","article-title":"A double blind comparing study between the effects of quetiapine and clozapine on the life quality of the patients with schizophrenia","volume":"17","author":"Li","year":"2005","journal-title":"Medical Journal of Chinese Peoples Health"},{"issue":"12","key":"10.1002\/14651858.CD006625.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"* Lieberman JA","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.genhosppsych.2008.09.012","article-title":"The impact of obesity on health care costs among persons with schizophrenia","volume":"31","author":"Chwastiak","year":"2009","journal-title":"General Hospital Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.schres.2008.07.006","article-title":"Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study","volume":"105","author":"Daumit","year":"2008","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","article-title":"Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial","volume":"64","author":"Keefe","year":"2007","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1176\/ajp.2007.164.7.1061","article-title":"Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison","volume":"164","author":"Keefe","year":"2007","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.schres.2008.04.023","article-title":"Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE schizophrenia trial phase 1","volume":"103","author":"Meyer","year":"2008","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.biopsych.2009.06.005","article-title":"Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study","volume":"66","author":"Meyer","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2005.07.015","article-title":"The clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial: clinical comparison of subgroups with and without the metabolic syndrome","volume":"80","author":"Meyer","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1192\/bjp.bp.108.050088","article-title":"Extrapyramidal side-effects of antipsychotics in a randomised trial","volume":"193","author":"Miller","year":"2008","journal-title":"The British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.schres.2005.07.034","article-title":"Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial","volume":"80","author":"Miller","year":"2005","journal-title":"Schizophrenia Research"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/schbul\/sbn067","article-title":"Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia","volume":"35","author":"Mohamed","year":"2009","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1176\/appi.ajp.2008.07111713","article-title":"Relationship of cognition and psychopathology to functional impairment in schizophrenia","volume":"165","author":"Mohamed","year":"2008","journal-title":"American Journal of Psychiatry"},{"issue":"7 Suppl 7","key":"10.1002\/14651858.CD006625.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1017\/S1092852900026663","article-title":"Metabolic findings from the CATIE trial and their relation to tolerability","volume":"11","author":"Nasrallah","year":"2006","journal-title":"CNS Spectrum"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2009.03.025","article-title":"Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study","volume":"111","author":"Patel","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.schres.2009.08.016","article-title":"The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial","volume":"115","author":"Penn","year":"2009","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4088\/JCP.v69n0114","article-title":"Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomised, double-blind, flexible-dose, multicenter study","volume":"69","author":"Perkins","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.schres.2009.09.026","article-title":"Impact of antipsychotic medication on family burden in schizophrenia: longitudinal results of CATIE trial","volume":"116","author":"Perlick","year":"2010","journal-title":"Schizophrenia Research"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11414-007-9101-3","article-title":"Employment outcomes in a randomised trial of second-generation antipsychotics and perphenazine in the treatment of individuals with schizophrenia","volume":"35","author":"Resnick","year":"2008","journal-title":"Journal of Behavioral Health Services and Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.schres.2008.09.031","article-title":"Data from the CATIE Trial","volume":"107","author":"Rosenheck","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.schres.2009.06.002","article-title":"The CATIE schizophrenia trial","volume":"113","author":"Rosenheck","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2005.08.007","article-title":"Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial","volume":"80","author":"Stroup","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.10.011","article-title":"Results of phase 3 of the CATIE schizophrenia trial","volume":"107","author":"Stroup","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1192\/bjp.bp.107.042630","article-title":"Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia","volume":"193","author":"Swanson","year":"2008","journal-title":"The British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/ajp.2007.164.3.428","article-title":"Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study","volume":"164","author":"Swartz","year":"2007","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1176\/ps.2008.59.5.500","article-title":"What CATIE found: results from the schizophrenia trial","volume":"59","author":"Swartz","year":"2008","journal-title":"Psychiatric Services"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.schres.2007.11.034","article-title":"The effectiveness of antipsychotic medications in patients who use of avoid illicit substances: results from the CATIE study","volume":"100","author":"Swartz","year":"2008","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0049|cit49","first-page":"6","article-title":"A controlled study of quetiapine and clozapine in the treatment of schizophrenia with predominantly negative symptoms","volume":"17","author":"Liu","year":"2004","journal-title":"Shandong Archires of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0050|cit50","first-page":"62","article-title":"A study of quetiapine and risperidone and clozapine in the treatment of schizophrenia","volume":"4","author":"Lu","year":"2006","journal-title":"China and Foreign Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0051|cit51","first-page":"191","article-title":"Comperison of quetiapine and aripiprazole in the treatment of first episode schizophrenia","volume":"18","author":"Luo","year":"2008","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0053|cit53","unstructured":"Keefe R Gu H Sweeney J Perkins D McEvoy J Hamer R Lieberman J A comparison of the effects of olanzapine, quetiapine, and risperidone on neurocognitive function in first-episode psychosis Proceedings of the 44th Annual Meeting of the American College of Neuropsychopharmacology, Waikoloa, Hawaii, December 11-15, 2005"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0054|cit54","unstructured":"Keefe RSE Gu H Sweeney JA Perkins DO McEvoy JP Hamer RM Lieberman JA The effects of olanzapine, quetiapine and risperidone on neurocognitive function in first-episode psychosis: a double-blind 52-week comparison Proceedings of the 159th Annual Meeting of the American Psychiatric Association, Toronto, Canada, May 20-25, 2006"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1176\/ajp.2007.164.7.1061","article-title":"Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison","volume":"164","author":"Keefe","year":"2007","journal-title":"American Journal of Psychiatry"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD006625.pub3-BIB0056|cit56","first-page":"S525","article-title":"Comparison of atypicals in first-episode psychosis: a randomized, 52-week comparison of olanzapine, quetiapine, and risperidone","volume":"15","author":"Lieberman","year":"2005","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0059|cit57","unstructured":"McEvoy JP Comparison of clozapine versus other atypical drugs in prospectively defined, unresponsive patients Proceedings of the 159th Annual Meeting of the American Psychiatric Association, May 20-25, 2006, Toronto, Canada"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0057|cit58","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1176\/ajp.2007.164.7.1050","article-title":"Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison","volume":"164","author":"McEvoy","year":"2007","journal-title":"American Journal of Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006625.pub3-BIB0058|cit59","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/S0920-9964(06)70390-5","article-title":"Clinical effectiveness and predictors of treatment non-adherence: comparison of olanzapine, quetiapine, and risperidone in first-episode psychosis","volume":"86","author":"McEvoy","year":"2006","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2009.03.025","article-title":"Metabolic profiles of second-generation antipsychotics in early psychosis: Findings from the CAFE study","volume":"111","author":"Patel","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4088\/JCP.v69n0114","article-title":"Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomised, double-blind, flexible-dose, multicenter study","volume":"69(1)","author":"Perkins","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.pnpbp.2004.01.019","article-title":"Effect of switching to atypical antipsychotics on memory in patients with chronic schizophrenia","volume":"28","author":"Mori","year":"2004","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0063|cit63","first-page":"190","article-title":"The metabolic and clinical effects of olanzapine and quetiapine: preliminary findings from a randomized single-blind trial in patients with schizophrenia","volume":"67","author":"Ozguven","year":"2004","journal-title":"Schizophrenia Research"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0064|cit64","first-page":"329","article-title":"A clinical analysis of aripiprazole and quetiapine in treatment of first episode schizophrenia","volume":"17","author":"Peng","year":"2007","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"45","key":"10.1002\/14651858.CD006625.pub3-BIB0065|cit65","first-page":"1","article-title":"Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial","volume":"6","author":"Gharabawi","year":"2006","journal-title":"BMC Psychiatry"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD006625.pub3-BIB0066|cit66","first-page":"S503","article-title":"Risperidone vs quetiapine in inpatients with schizophrenia: a double-blind placebo-controlled study","volume":"15","author":"Greenspan","year":"2005","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"1-3","key":"10.1002\/14651858.CD006625.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.schres.2006.03.027","article-title":"A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization","volume":"85","author":"Potkin","year":"2006","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0068|cit68","first-page":"501","article-title":"A placebo-controlled study of risperidone vs quetiapine for symptom response and readiness for discharge among agitated inpatients with schizophrenia","volume":"31","author":"Potkin","year":"2005","journal-title":"Schizophrenia Bulletin"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00406-005-0622-6","article-title":"Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms","volume":"255","author":"Riedel","year":"2005","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0070|cit70","doi-asserted-by":"crossref","unstructured":"Riedel M Spellmann I Muller N Strassnig M Muller-Arends A Dehning S Moller HJ Cognitive benefits of quetiapine versus risperidone in schizophrenia Proceedings of the 158th Annual Meeting of the American Psychiatric Association, Atlanta GA, USA, May 21-26, 2005","DOI":"10.1055\/s-2005-918844"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00406-007-0739-x","article-title":"Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms","volume":"257","author":"Riedel","year":"2007","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"7","key":"10.1002\/14651858.CD006625.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00406-007-0748-9","article-title":"Efficacy of olanzapine versus quetiapine on cognitive dysfunctions with an acute episode of schizophrenia","volume":"257","author":"Riedel","year":"2007","journal-title":"European Archieves of Psychiatry and Clinical Neuroscience"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0073|cit73","first-page":"150","article-title":"Comparison of quetiapine, olanzapine and risperidone in patients with schizophrenia: interim results of a randomised, rater-blinded study","volume":"67","author":"Sacchetti","year":"2004","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0077|cit74","doi-asserted-by":"crossref","unstructured":"Sacchetti E Valsecchi P Regini C Galluzzo A Cacciani P Comparison of quetiapine, olanzapine and risperidone in a randomized study in patients with schizophrenia Proceedings of the Thematic Conference of the World Psychiatric Association on \"Treatments in Psychiatry: An Update\", Florence, Italy, November 10-13, 2004","DOI":"10.1016\/S0924-977X(03)92114-6"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0074|cit75","doi-asserted-by":"crossref","first-page":"S350","DOI":"10.1016\/S0924-977X(03)92114-6","article-title":"Comparison of quetiapine, olanzapine and risperidone in patients with schizophrenia: interim results of a randomised, rater-blinded study","volume":"13","author":"Sacchetti","year":"2003","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD006625.pub3-BIB0075|cit76","doi-asserted-by":"crossref","first-page":"S286","DOI":"10.1016\/S0924-977X(04)80342-0","article-title":"Comparison of quetiapine, olanzapine, and risperidone in schizophrenia","volume":"14","author":"Sacchetti","year":"2004","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0076|cit77","unstructured":"Sacchetti E Valsecchi P Regini C Galluzzo A Cacciani P Agrimi E Comparison of quetiapine, olanzapine and risperidone in patients with schizophrenia: interim results of a randomised, rater-blinded study Proceedings of the 16th European College of Neuropsychopharmacology Congress, Prague, Czech Republic, September 20-24, 2003"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/hup.763","article-title":"Quetiapine versus olanzapine for the treatment of negative symptoms in patients with schizophrenia","volume":"21","author":"Sirota","year":"2006","journal-title":"Human Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0079|cit79","first-page":"170","article-title":"The effectiveness of quetiapine versus olanzapine in improving negative symptoms of patients with schizophrenia","volume":"67","author":"Sirota","year":"2004","journal-title":"Schizophrenia Research"},{"issue":"32","key":"10.1002\/14651858.CD006625.pub3-BIB0080|cit80","first-page":"4961","article-title":"Control study of risperidone oral solution and quetiapine on schizophrenia","volume":"17","author":"Song","year":"2008","journal-title":"Modern Journal of Integrated Traditional Chinese and Western Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1176\/ajp.2006.163.4.611","article-title":"Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic","volume":"163","author":"Stroup","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1016\/S0924-977X(03)91983-3","article-title":"A double-blind comparison of olanzapine and quetiapine in treatment of acute exacerbations of schizophrenic or schizoaffective disorders","volume":"13","author":"Svestka","year":"2003","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0083|cit83","doi-asserted-by":"crossref","unstructured":"Voruganti LP Awad AG Parker G Forrest C Usmani Y Fernando MLD Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine Schizophrenia Research 2007 146 55","DOI":"10.1016\/j.schres.2007.08.002"},{"issue":"18","key":"10.1002\/14651858.CD006625.pub3-BIB0084|cit84","first-page":"1697","article-title":"A control study of quetiapine and risperidone in the treatment of schizophrenia","volume":"35","author":"Wang","year":"2006","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0085|cit85","first-page":"34","article-title":"A comparative study of social function in first-episode schizophrenic patients treated with quetiapine and risperidone","volume":"19","author":"Wei","year":"2006","journal-title":"Shandong Archives of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0086|cit86","first-page":"511","article-title":"Dummy parallel controlled study in the female first-episode schizophrenia treated with aripiprazole and quetiapine","volume":"32","author":"Wei","year":"2006","journal-title":"Chinese Journal of Nervous and Mental Disorders"},{"issue":"11","key":"10.1002\/14651858.CD006625.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1176\/ajp.2006.163.11.1918","article-title":"Improvement in social competence with short-term atypical antipsychotic treatment: a randomized, double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning","volume":"163","author":"Harvey","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD006625.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.4088\/JCP.v67n0712","article-title":"Comparison of quetiapine and risperidone in the treatment of schizophrenia: a randomized, double-blind, flexible-dose, 8-week study","volume":"67","author":"Zhong","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0089|cit89","first-page":"152","article-title":"A comparative study between quetiapine and clozapine in the treatment of schizophrenia and the relation with the plasman levels of IL-2, SIL-2R","volume":"16","author":"An","year":"2003","journal-title":"Schuan Mental Health"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0090|cit90","first-page":"84","article-title":"Comparitive study between the effect olanzapine and quetiapine in first-episode schizophrenia","volume":"16","author":"An","year":"2006","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0091|cit91","first-page":"340","article-title":"A study on the executive function of first episode paranoid schizophrenia","volume":"15","author":"An","year":"2006","journal-title":"Chinese Journal of Behavioral Medical Science"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0092|cit92","first-page":"474","article-title":"Superior cognitive efficacy of atypical antipsychotics olanzapine, risperidone, and quetiapine, as a group, relative to low doses of conventional antipsychotics","volume":"31","author":"Antonova","year":"2005","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00787-009-0749-5","article-title":"Olanzapine compared to quetiapine in adolescents with a first psychotic episode","volume":"18","author":"Arango","year":"2009","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD006625.pub3-BIB0094|cit94","first-page":"1","article-title":"Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia","volume":"6","author":"Ascher-Svanum","year":"2006","journal-title":"BMC Psychiatry"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD006625.pub3-BIB0095|cit95","first-page":"S403","article-title":"Side effects of atypical antipsychoticsprediction factor for compliance","volume":"16","author":"Baloescu","year":"2006","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0096|cit96","first-page":"292","article-title":"Analysis of the efficacy of aripiprazole and quetiapine in the treatment of schizophrenia","volume":"24","author":"Ban","year":"2008","journal-title":"Occupation and Health"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0097|cit97","unstructured":"Beuzen J-N Pans M Modell S Hagens P McQuade R Iwamoto T Naturalistic study of aripiprazole treatment Proceedings of the XIII World Congress of Psychiatry, Cairo, Egypt, September 10-15, 2005"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.schres.2009.09.019","article-title":"Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST)","volume":"115","author":"Boter","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.schres.2009.09.022","article-title":"Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study","volume":"115","author":"Galderisi","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1085\u201397","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0101|cit101","unstructured":"Brecher M Newcomer JW Ratner RE Eriksson JW Emsley R Meulien D Differential effects of quetiapine, olanzapine and risperidone on glucose metabolism: a 24-week study in schizophrenia International Congress on Schizophrenia Research 2007"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0102|cit102","unstructured":"Byerly M Weber M Clozapine versus quetiapine for schizophrenia Stanley Foundation Research Programs 1999"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0103|cit103","unstructured":"Byerly MJ Nakonezny P Bugno R Boles J A randomized, double-blind pilot trial of switching to quetiapine vs. risperidone continuation in outpatients with risperidone-associated sexual dysfunction Proceedings of the 159th Annual Meeting of the American Psychiatric Association, Toronto, Canada, May 20-25, 2006"},{"issue":"8","key":"10.1002\/14651858.CD006625.pub3-BIB0104|cit104","first-page":"465","article-title":"A control study of quetiapine and clozapine in the treatment of schizophrenia","volume":"3","author":"Cai","year":"2005","journal-title":"The Medicine Magazine of China"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0105|cit105","unstructured":"Canas F Perez V Tafalla M Quetiapine and risperidone in the treatment of schizophrenia: a short- and long-term, non-randomized study Proceedings of the 159th Annual Meeting of the American Psychiatric Association, Toronto, Canada, May 20-25, 2006"},{"issue":"36","key":"10.1002\/14651858.CD006625.pub3-BIB0106|cit106","first-page":"63","article-title":"Characteristics of the sexual disturbance caused by chlorpromazine, risperidone, quetiapine and olanzapine and their associations with the changes of blood glucose and blood lipids in male patients with schizophrenia","volume":"9","author":"Cao","year":"2005","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"20","key":"10.1002\/14651858.CD006625.pub3-BIB0107|cit107","first-page":"148","article-title":"Comparison of the effects of chlorpromazine, risperidone and quetiapine on hypothalamic-pituitary-gonadal axis and sexual function in male patients with schizophrenia","volume":"9","author":"Cao","year":"2005","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0108|cit108","first-page":"209","article-title":"Effects of antipsychotic on pituitary-gonadal axis in male patients with schizophrenia","volume":"16","author":"Cao","year":"2006","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0109|cit109","first-page":"433","article-title":"Comparison of curative effect and safety of quetiapine and risperidone in the treatment of female schizophrenia","volume":"18","author":"Cao","year":"2006","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"34","key":"10.1002\/14651858.CD006625.pub3-BIB0110|cit110","first-page":"52","article-title":"A control study of quetiapine and risperidone in the treatment of schizophrenia","volume":"2","author":"Chang","year":"2007","journal-title":"China Practice Medicine"},{"issue":"17","key":"10.1002\/14651858.CD006625.pub3-BIB0111|cit111","first-page":"2010","article-title":"A control study of quetiapine and risperidone in the treatment of schizophrenia","volume":"20","author":"Chang","year":"2008","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD006625.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1016\/S0924-977X(06)70201-2","article-title":"Comparison of risperidone, olanzapine and quetiapine in relation to body weight, serum blood glucose and prolactin levels","volume":"16","author":"Chaudhry","year":"2006","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0113|cit113","first-page":"548","article-title":"A control study of quetiapine and risperidone in the treatment of female schizophrenia","volume":"25","author":"Chen","year":"2006","journal-title":"Herald of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0114|cit114","first-page":"447","article-title":"A study of quetiapine on the quality of life of elderly schizophrenia","volume":"18","author":"Chen","year":"2006","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"9","key":"10.1002\/14651858.CD006625.pub3-BIB0115|cit115","first-page":"43","article-title":"Control study on management of first-episode schizophrenia with risperidone and quetiapine","volume":"16","author":"Chen","year":"2007","journal-title":"China Pharmaceuticals"},{"issue":"10","key":"10.1002\/14651858.CD006625.pub3-BIB0116|cit116","first-page":"917","article-title":"A control study of quetiapine vs risperidone in first-episode schizophrenia","volume":"42","author":"Chen","year":"2007","journal-title":"Jiangxi Medicine"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0117|cit117","first-page":"381","article-title":"A control study of quetiapine and aripiprazole in the treatment of female first-episode schizophrenia","volume":"20","author":"Chen","year":"2007","journal-title":"Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0118|cit118","first-page":"389","article-title":"A control study of quetiapine and risperidone in the treatment of schizophrenia","volume":"21","author":"Chen","year":"2008","journal-title":"Medical Information"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0119|cit119","first-page":"34","article-title":"Comparative study of quetiapine and risperidone in the treatment of late onset schizophrenias","volume":"16","author":"Chu","year":"2006","journal-title":"Journal of Clinical Psychological Medicine"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/jcp.0b013e318160864f","article-title":"Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia","volume":"28","author":"Cortese","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0121|cit121","first-page":"291","article-title":"Comparative study on the effect of olanzapine and seroquel of schizophrenia","volume":"13","author":"Dai","year":"2004","journal-title":"Chinese Journal of Behavioral Medical Science"},{"issue":"8","key":"10.1002\/14651858.CD006625.pub3-BIB0122|cit122","first-page":"712","article-title":"Comparison of efficacy and safety of aripiprazole and quetiapine in the treatment of schizophrenia","volume":"14","author":"Dai","year":"2005","journal-title":"Chinese Journal of Behavioral Medical Sience"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0123|cit123","first-page":"10","article-title":"The effects of seroquel and risperidone on serum prolactin levels of female schizophrenia","volume":"2","author":"Dai","year":"2008","journal-title":"Chinese Journal of Modern Drug Application"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1524-4733.2007.00280.x","article-title":"Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy","volume":"11","author":"Davies","year":"2008","journal-title":"Value in Health"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0125|cit125","first-page":"76","article-title":"A comparative study of risperidone and quetiapine in the treatment of schizophrenia and relationship between efficacy and the serum levels of il-2?sil-2r","volume":"17","author":"Ding","year":"2004","journal-title":"Shandong Archives of Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD006625.pub3-BIB0126|cit126","first-page":"1275","article-title":"A control study of quetiapine and ziprasidone in the treatment of first-episode schizophrenia","volume":"20","author":"Dong","year":"2008","journal-title":"Medical Journal of Chinese People's Health"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4088\/JCP.v66n0810","article-title":"Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the intercontinental schizophrenia outpatient health outcomes (IC-SOHO) study","volume":"66","author":"Dossenbach","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0128|cit128","first-page":"511","article-title":"A study of quetiapine and clozapine in treatment of chronic schizophrenia","volume":"26","author":"Feng","year":"2003","journal-title":"Journal of Luzhou Medical College"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1017\/S1461145705005067","article-title":"Effects of quetiapine and haloperidol on body mass index and glycaemic control: a long-term, randomized, controlled trial","volume":"8","author":"Emsley","year":"2005","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0130|cit130","first-page":"178","article-title":"A study of quetiapine in treatment of negative symptoms dominant schizophrenia","volume":"18","author":"Fan","year":"2005","journal-title":"Sichuan Mental Health"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0131|cit131","first-page":"14","article-title":"The effects of quetiapine, risperidone and clozapine for schizophrenia on serum prolactin level","volume":"25","author":"Fan","year":"2008","journal-title":"Chinese Medical Journal of Metallurgical Industry"},{"issue":"2-3","key":"10.1002\/14651858.CD006625.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2005.06.004","article-title":"The European First Episode Schizophrenia Trial (EUFEST): rationale and design of the trial","volume":"78","author":"Fleischhacker","year":"2005","journal-title":"Schizophrenia Research"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0133|cit133","first-page":"313","article-title":"A comparative study of quetiapine vs clozapine in the treatment of schizophrenia","volume":"11","author":"Fu","year":"2005","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0134|cit134","first-page":"313","article-title":"A comparative study of quetiapine vs clozapine in the treatment of schizophrenia","volume":"11","author":"Fu","year":"2005","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0135|cit135","first-page":"221","article-title":"A study of quetiapine in the treatment of first-onset schizophrenia","volume":"13","author":"Gao","year":"2003","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD006625.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"S378","DOI":"10.1016\/S0924-977X(06)70455-2","article-title":"Sexual side effects of antipsychotics and treatment adherence","volume":"16","author":"Garc\u00eda","year":"2006","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0137|cit137","first-page":"544","article-title":"Efficacy quetiapine in the treatment of schizophrenic patients and effect on the quality of life","volume":"16","author":"Guo","year":"2008","journal-title":"China Journal of Health Psychology"},{"issue":"15","key":"10.1002\/14651858.CD006625.pub3-BIB0138|cit138","first-page":"60","article-title":"A control study of quetiapine and seroquel in the treatment of schizophrenia","volume":"28","author":"Hao","year":"2007","journal-title":"Journal of Medical Forum"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/01.jcp.0000104913.75206.62","article-title":"A randomized evaluation of the effects of six antipsychotic agents on QTC, in the absence and presence of metabolic inhibition","volume":"24","author":"Harrigan","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0140|cit140","first-page":"335","article-title":"A controlled study on quetiapine and clozapine in the treatment of schizophrenic patients","volume":"15","author":"He","year":"2003","journal-title":"Medical Journal of Chinese Civil Administration"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0141|cit141","unstructured":"Horacek J Seifertova D Janu L Petranova T The effect of quetiapine on different domains of cognition and negative symptoms in schizophrenia Proceedings of the Biennial Winter Workshop on Schizophrenia, February 7-13, 2004"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0142|cit142","first-page":"206","article-title":"Effectiveness of quetiapine vs clozapine in the treatment of schizophrenia","volume":"9","author":"Huang","year":"2003","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0143|cit143","first-page":"264","article-title":"Effects of clozapine and seroquel on the glucose metabolism in schizophrenic patients","volume":"41","author":"Huang","year":"2006","journal-title":"Jiangxi Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1600-0447.2003.00251.x","article-title":"Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis","volume":"109","author":"Huber","year":"2004","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"8","key":"10.1002\/14651858.CD006625.pub3-BIB0145|cit145","first-page":"1327","article-title":"A control study of quetiapine and aripiprozole in the treatment of schizophrenia","volume":"23","author":"Jiang","year":"2006","journal-title":"Journal of Clinical Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1052-z","article-title":"Subjective well-being and quality of life under atypical antipsychotic treatment","volume":"162","author":"Karow","year":"2002","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13651500600579068","article-title":"Clinical experience with atypical antipsychotics in acute inpatient unit: focus on quetiapine","volume":"10","author":"Keks","year":"2006","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD006625.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.1016\/S0924-977X(06)70549-1","article-title":"Do second-generation antipsychotics disrupt decision-making abilities in schizophrenia?","volume":"16","author":"Kelemen","year":"2006","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD006625.pub3-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.1016\/S0924-977X(04)80250-5","article-title":"The comparison of risperidone, olanzapine and quetiapine in the treatment of chronic schizophrenia and schizoaffective disorder","volume":"14","author":"Kim","year":"2004","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/01.jcp.0000106220.36344.04","article-title":"A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning","volume":"24","author":"Knegtering","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.eurpsy.2008.01.1421","article-title":"Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care","volume":"23","author":"Kolotkin","year":"2008","journal-title":"European Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0152|cit152","unstructured":"Koponen Study in Schizophrenic In-Patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose Clinical Trial Registration Data 2008"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0153|cit153","first-page":"217","article-title":"A comparative study on the efficacy and weight gain between quetiapine and clozapine in the treatment of schizophrenia","volume":"20","author":"Kuang","year":"2007","journal-title":"Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0154|cit154","unstructured":"L\u2019Italien G Hanssens L Kan HJ Baker RA Marcus RN McQuade RD Metabolic effects of aripiprazole versus olanzapine, quetiapine, or risperidone (the Star trial) Proceedings of the 11th International Congress on Schizophrenia Research, Colorado Springs, Colorado, USA, March 28-April 1, 2007"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0155|cit155","first-page":"850","article-title":"A control study of quetiapine and clozapine in the treatment of schizophrenia","volume":"26","author":"Lan","year":"2006","journal-title":"Journal of Ganna Medical University"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0156|cit156","first-page":"260","article-title":"Quetiapine in treatment of schizophrenia: a randomized, controlled, multicentre study","volume":"20","author":"Li","year":"2001","journal-title":"Chinese Journal of New Drugs and Clinical Remedies"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0157|cit157","first-page":"267","article-title":"A comparative study between quetiapine and clozapine in the treatment of schizophrenia","volume":"12","author":"Li","year":"2002","journal-title":"Jiuheyuan Hospital of Shishou"},{"issue":"12","key":"10.1002\/14651858.CD006625.pub3-BIB0158|cit158","first-page":"718","article-title":"A comparison of cognitive function in the first-onset schizophrenia treated with quetiapine and clozapine","volume":"15","author":"Li","year":"2003","journal-title":"Medical Journal of Chinese People Health"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0159|cit159","first-page":"45","article-title":"Comparison of efficacy and safety of seroquel and resperidone in the treatment of schizophrenia","volume":"12","author":"Li","year":"2003","journal-title":"Chinese Journal of Behavioral Medical Science"},{"issue":"7","key":"10.1002\/14651858.CD006625.pub3-BIB0160|cit160","first-page":"33","article-title":"A controlled study of schizophrenia treated with quetiapine and clozapine","volume":"3","author":"Li","year":"2005","journal-title":"Chinese Modern Medical and Clinical"},{"issue":"11","key":"10.1002\/14651858.CD006625.pub3-BIB0161|cit161","first-page":"1007-8, 1036","article-title":"A comparison analysis on the efficacy of quetiapine and risperidone in cognitive function of schizophrenia","volume":"14","author":"Li","year":"2005","journal-title":"Chinese Journal of Behavioral Medical Science"},{"issue":"11","key":"10.1002\/14651858.CD006625.pub3-BIB0162|cit162","first-page":"49","article-title":"A control study of quetiapine and aripiprazole in the treatment of schizophrenia","volume":"30","author":"Li","year":"2007","journal-title":"Chinese Journal of Postgraduate Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0163|cit163","first-page":"354","article-title":"Comparison of efficacy and safety of seroquel and risperidone in the treatment of schizophrenia","volume":"22","author":"Li","year":"2007","journal-title":"Huaxi Pharmacy"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0164|cit164","first-page":"42","article-title":"A comparison analysis on the efficacy of quetiapine and risperidone in the treatment of schizophrenia","volume":"20","author":"Li","year":"2008","journal-title":"Tianjin Pharmacy"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0165|cit165","first-page":"31","article-title":"A control study of quetiapine and olanzapine in the treatment of schizophrenia","volume":"30","author":"Li","year":"2008","journal-title":"Journal of Nongken Medicine"},{"issue":"12","key":"10.1002\/14651858.CD006625.pub3-BIB0166|cit166","first-page":"2253","article-title":"Influence on the psychopathology and the quality of life of schizophrenia treated with risperidone, clozapine and quetiapine","volume":"21","author":"Li","year":"2008","journal-title":"Medical Information"},{"issue":"19","key":"10.1002\/14651858.CD006625.pub3-BIB0167|cit167","first-page":"1162","article-title":"The cross-check analysis of risperdal and quetiapine alleviating negative symptoms of schizophrenia","volume":"5","author":"Li","year":"2008","journal-title":"Laboratory Medicine and Clinic"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0168|cit168","first-page":"296","article-title":"Influence of quetiapine and clozapine on fasting blood glucose of first-episode schizophrenia","volume":"11","author":"Liang","year":"2008","journal-title":"Practical Pharmacy and Clinical Remedies"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0169|cit169","first-page":"1299","article-title":"Analysis of therapeutic effect of quetiapine on schizophrenia patient","volume":"5","author":"Lin","year":"2005","journal-title":"China Tropical Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0170|cit170","first-page":"67","article-title":"A study of quetiapine in the treatment of elderly schizophrenia","volume":"37","author":"Lin","year":"2007","journal-title":"Qinghai Pharmacy"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0171|cit171","first-page":"230","article-title":"A comparative study of new anti-psychopathic drugs lead to gain weight","volume":"15","author":"Liu","year":"2003","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0172|cit172","first-page":"37","article-title":"A control study of quetiapine and risperidone in the treatment of schizophrenia","volume":"16","author":"Liu","year":"2003","journal-title":"Journal of Hebei Mental Health"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0173|cit173","first-page":"6","article-title":"A controlled study of quetiapine and clozapine in the treatment of schizophrenia with predominantly negative symptoms","volume":"17","author":"Liu","year":"2004","journal-title":"Shandong Archires of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0174|cit174","first-page":"6","article-title":"A controlled study of quetiapine and clozapine in the treatment of schizophrenia with predominantly negative symptoms","volume":"17","author":"Liu","year":"2004","journal-title":"Shandong Archires of Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0175|cit175","first-page":"748","article-title":"A study of quetiapine with small doze of clozapine in treatment of resistant schizophrenia","volume":"17","author":"Liu","year":"2005","journal-title":"Medical Journal of Chinese People\u00b4s Health"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0176|cit176","first-page":"15","article-title":"A comparative study between quetiapine and risperidone in the treatment of schizophrenia","volume":"17","author":"Liu","year":"2005","journal-title":"Journal of Heze Medical College"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0177|cit177","first-page":"14","article-title":"Study on quetiapine fumarate and risperidone in the treatment of schizophrenia","volume":"23","author":"Liu","year":"2006","journal-title":"Journal of Hebei Medical College for Continuing Education"},{"issue":"18","key":"10.1002\/14651858.CD006625.pub3-BIB0178|cit178","first-page":"24","article-title":"Clinical study on quetiapine in treatment of refractory schizophrenia","volume":"45","author":"Liu","year":"2007","journal-title":"China Modern Doctor"},{"issue":"7","key":"10.1002\/14651858.CD006625.pub3-BIB0179|cit179","first-page":"639","article-title":"A control study of quetiapine and risperidone in the treatment of elderly schizophrenia","volume":"20","author":"Liu","year":"2008","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0180|cit180","first-page":"57","article-title":"Comparative study on the psychopathology and the quality of life of schizophrenia treated with risperidone, clozapine and quetiapine","volume":"20","author":"Lu","year":"2005","journal-title":"Journal of Nursing Science"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0181|cit181","first-page":"269","article-title":"The comparative study of quetiapine and clozapine in the treatment of female schizophrene","volume":"17","author":"Luo","year":"2005","journal-title":"Medical Journal of Chinese People Health"},{"issue":"16","key":"10.1002\/14651858.CD006625.pub3-BIB0182|cit182","first-page":"91","article-title":"A control study of quetiapine and risperidone in the treatment of eldly schizophrenia","volume":"48","author":"Lv","year":"2008","journal-title":"Shandong Pharmacy"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0183|cit183","first-page":"1176","article-title":"Clinical observation on acute excitation of schizophrenia treated with quetiapine","volume":"20","author":"Mei","year":"2006","journal-title":"Chinese Nursing Research"},{"issue":"9","key":"10.1002\/14651858.CD006625.pub3-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1185\/030079904X2312","article-title":"A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone","volume":"20","author":"Mintzer","year":"2004","journal-title":"Current Medical Research and Opinion"},{"issue":"11","key":"10.1002\/14651858.CD006625.pub3-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0149-2918(00)89080-3","article-title":"A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study","volume":"23","author":"Mullen","year":"2001","journal-title":"Clinical Therapeutics"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD006625.pub3-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"S415","DOI":"10.1016\/S0924-977X(06)70522-3","article-title":"SNAP-25 gene polymorphisms and weight gain in schizophrenic patients treated with atypical antipsychotics","volume":"16","author":"Musil","year":"2006","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0187|cit187","first-page":"38","article-title":"Effect of quetiapine on cognitive function of patients with first episode schizophrenia","volume":"28","author":"Nai","year":"2007","journal-title":"Journal of Medical Forum"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0188|cit188","first-page":"244","article-title":"A controlled study of domestic quetiapine and risperidone in the treatment of first-episode schizophrenia","volume":"10","author":"Pan","year":"2004","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"issue":"10","key":"10.1002\/14651858.CD006625.pub3-BIB0189|cit189","first-page":"597-8, 637","article-title":"A comparative study of domestic quetiapine and risperidone in the treatment of schizophrenia","volume":"16","author":"Pan","year":"2004","journal-title":"Medical Journal of Chinese Peoples Health"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0190|cit190","first-page":"403","article-title":"Influence of three antipsychotic drugs on electrocardiogram in patients with schizophrenia","volume":"21","author":"Pan","year":"2004","journal-title":"Journal of XinXiang Medical College"},{"issue":"13","key":"10.1002\/14651858.CD006625.pub3-BIB0191|cit191","first-page":"22","article-title":"A study of ziprasidone in the treatment of schizophrenia","volume":"6","author":"Pan","year":"2008","journal-title":"Guide of China Medicine"},{"issue":"7","key":"10.1002\/14651858.CD006625.pub3-BIB0192|cit192","first-page":"1007","article-title":"Effect of quetiapine fumarate and clozapine on clinical rehabilitation of schizophrenia:a controlled study","volume":"6","author":"Pang","year":"2002","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"12","key":"10.1002\/14651858.CD006625.pub3-BIB0193|cit193","first-page":"1557","article-title":"Control study of quetiapine on schizophrenia mainly with negative symptoms","volume":"13","author":"Peng","year":"2004","journal-title":"Modern Journal of Integrated Traditional Chinese and Western Medicine"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0194|cit194","unstructured":"Petty F Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia Clinical Trial Registration Data 2006"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0195|cit195","unstructured":"Pfizer Effect and Safety of Ziprasidone Compared to Other Atypical Antipsychotic Drug in Schizophrenic Patients Clinical Trial Registration Data 2005"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0196|cit196","first-page":"78-9, 119","article-title":"Comparison of efficacy and safety of quetiapine and risperidone in the treatment of schizophrenia","volume":"16","author":"Qi","year":"2004","journal-title":"Shanghai Archives of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0197|cit197","first-page":"110","article-title":"Cost-effectiveness analysis of 3 kinds of therapeutic schemes for schizophrenia","volume":"4","author":"Qian","year":"2004","journal-title":"Evaluation and Analysis of Drug Use in Hospital of China"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0198|cit198","unstructured":"Reznik I Slavkin L Shabash E Shaked G Kertzman S Spivak B Quetiapine (\"Seroquel\") and olanzapine for acute treatment of patients with schizophrenia: an open-label, comparative study Proceedings of the XXIV Collegium Internationale Neuro-Psychopharmacologicum; Paris, France, June 20-24, 2004 1 4"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0199|cit199","unstructured":"Riera L Tandon R Stock EG Kujawa MJ Torbeyns AF Borian FE Broad effectiveness trial with aripiprazole Proceedings of the Twelfth Biennial Winter Workshop on Schizophrenia, Davos, Switzerland, February 7-13, 2004"},{"issue":"12","key":"10.1002\/14651858.CD006625.pub3-BIB0200|cit200","first-page":"747","article-title":"A control study of quetiapine and clozapine in the treatment of difficult-to-treat schizophrenia","volume":"17","author":"Ruan","year":"2005","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD006625.pub3-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"S419","DOI":"10.1016\/S0924-977X(06)70530-2","article-title":"Association of leptin gene polymorphism with antipsychotic drug-induced weight gain","volume":"16","author":"Ryu","year":"2006","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0202|cit202","unstructured":"Sajatovic M Mullen JA Sweitzer D Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychotic disorders Proceedings of the 155th Annual Meeting of the American Psychiatric Association, Philadelphia, Pennsylvania, USA, May 18-23, 2002"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0203|cit203","unstructured":"Sarma K Lurasidone HCl - A Long Term Phase 3 Study ofPatients With Chronic Schizophrenia (PEARL 3Ext) Clinical Trial Registration Data 2008"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0204|cit204","first-page":"304","article-title":"A study of cognitive function about quetiapine and clozapine in the treatment of schizophrenia","volume":"16","author":"Sheng","year":"2006","journal-title":"Journal of Clinical Psychological Medicine"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0205|cit205","first-page":"91","article-title":"A control study of quetiapine and clozapine in the treatment of schizophrenia","volume":"(7)","author":"Song","year":"2006","journal-title":"Health Horizon\u00b7Medical Science Fascicule"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0206|cit206","first-page":"133","article-title":"A control study of quetiapine and clozapine in the treatment of schizophrenia of quality of life","volume":"18","author":"Song","year":"2008","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"23","key":"10.1002\/14651858.CD006625.pub3-BIB0207|cit207","first-page":"2790","article-title":"A control study of quetiapine and clozapine in the treatment of chronic schizophrenia","volume":"20","author":"Song","year":"2008","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0208|cit208","first-page":"141","article-title":"A control study of quetiapine and clozapine in the treatment of children's first-episode schizophrenia","volume":"19","author":"Sun","year":"2006","journal-title":"Shandong Archives of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0209|cit209","first-page":"94","article-title":"Effect of cognitive function in first-episode schizophrenia treated with quetiapine","volume":"16","author":"Sun","year":"2006","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0210|cit210","first-page":"150","article-title":"Clinical comparative study of ziprasidone in the treatment of schizophrenia","volume":"20","author":"Sun","year":"2007","journal-title":"Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0211|cit211","first-page":"407","article-title":"A control study on quetiapine in gerontic first-episode schizophrenia","volume":"13","author":"Sun","year":"2007","journal-title":"Journal of Chinese Psychosomatic Disorders"},{"issue":"21","key":"10.1002\/14651858.CD006625.pub3-BIB0212|cit212","first-page":"97","article-title":"A control study of quetiapine and clozapine in the treatment of schizophrenia","volume":"2","author":"Sun","year":"2007","journal-title":"China Practical Medicine"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0213|cit213","first-page":"14","article-title":"A comparative study of quetiapine and risperidone in the treatment of old men with schizophrenia","volume":"20","author":"Sun","year":"2008","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YIC.0b013e3283320511","article-title":"A trial of quetiapine compared with risperidone in the treatment of first onset psychosis among 15- to 18-year-old adolescents","volume":"25","author":"Swadi","year":"2010","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0215|cit215","unstructured":"Swanson JW Swartz MS Van Dorn RA Effectiveness of atypical antipsychotics for substance abuse in schizophrenia patients Proceedings of the 159th Annual Meeting of the American Psychiatric Association, Toronto, Canada, May 20-25, 2006"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0216|cit216","first-page":"27","article-title":"A controlled study of schizophrenia treated with quetiapine and clozapine","volume":"15","author":"Tang","year":"2003","journal-title":"Shanghai Archives of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0217|cit217","first-page":"167","article-title":"A comparative study of quetiapine and clozapine in the treatment of recurrent schizophrenia","volume":"18","author":"Tang","year":"2005","journal-title":"Shandong Archives of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0218|cit218","first-page":"7","article-title":"A comparison of the effects on lipid metabolic among four different atypical antipsychotic agents","author":"Tao","year":"2008","journal-title":"Journal of Youjiang Medical College"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0219|cit219","first-page":"25","article-title":"A comparative study between seroquel and risperidone in the treatment of schizophrenia","volume":"19","author":"Tian","year":"2006","journal-title":"Shandong Archives of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0220|cit220","first-page":"133","article-title":"Control studies on the curative effect and influence of quetiapine and clozapine on quality of life of schizophrenics","volume":"13","author":"Tian","year":"2007","journal-title":"J Clin Psychosom Disease"},{"issue":"18","key":"10.1002\/14651858.CD006625.pub3-BIB0221|cit221","first-page":"2119","article-title":"A comparative study of new antipsychopathic drugs lead to gain weight","volume":"20","author":"Tian","year":"2008","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0222|cit222","first-page":"200","article-title":"A controlled study on seroquel and risperidone in the treatment of schizophrenic patients","volume":"10","author":"Wang","year":"2000","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0223|cit223","first-page":"167","article-title":"Comparative study of effects of quetiapine and clozapine on quality of life of schizophrenics","volume":"10","author":"Wang","year":"2004","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0224|cit224","first-page":"551","article-title":"Comparation of quetiapine and clozapine in treatment of patients with first-onset schizophrenia","volume":"9","author":"Wang","year":"2004","journal-title":"Chinese Journal of Clinical Pharmacology and Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0225|cit225","first-page":"333","article-title":"Cognitive function and p300 potentials in first-episode schizophrenia treated with quetiapine and risperidone","volume":"19","author":"Wang","year":"2005","journal-title":"Chinese Mental Health Journal"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0226|cit226","first-page":"168","article-title":"Comparison of cognitive function and event related potentials in first episode schizophrenic treated with antipsychotic drugs","volume":"15","author":"Wang","year":"2005","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0227|cit227","first-page":"118","article-title":"Clinical study of quetiapine and risperidone in the treatment of schizophrenia","volume":"11","author":"Wang","year":"2005","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0228|cit228","first-page":"235","article-title":"Analysis of quetiapine in treatment of first-episode schizophrenia","volume":"18","author":"Wang","year":"2005","journal-title":"Sichuan Mental Health"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0229|cit229","first-page":"271","article-title":"A comparative study between quetiapine and clozapine in the treatment of schizophrenia","volume":"13","author":"Wang","year":"2005","journal-title":"Heath Psychology Journal"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0230|cit230","first-page":"815","article-title":"Comparative study of guetiapine and risperidone in the treatment of schizophrenia","volume":"22","author":"Wang","year":"2006","journal-title":"Modern Medicine Health"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0231|cit231","first-page":"416","article-title":"Effects of quetiapine vs clozapine on the quality of life in first-episode schizophrenics","volume":"12","author":"Wang","year":"2006","journal-title":"Journal of Clinical Psychosomatic Disorders"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0232|cit232","first-page":"165","article-title":"A study of quetiapine and risperidone in treatment of chronic schizophrenia","volume":"17","author":"Wang","year":"2007","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0233|cit233","first-page":"199","article-title":"A control study of quetiapine and risperidone in the treatment of children's schizophrenia","volume":"17","author":"Wang","year":"2007","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"32","key":"10.1002\/14651858.CD006625.pub3-BIB0234|cit234","first-page":"2487","article-title":"Non-classical antipsychotic drugs for schizophrenia :cost minimization analysis on 3 schemes","volume":"18","author":"Wang","year":"2007","journal-title":"China Pharmacy"},{"issue":"11","key":"10.1002\/14651858.CD006625.pub3-BIB0235|cit235","first-page":"1137","article-title":"A comparative study of social function in schizophrenia patients treated with seroquel or clozapine","volume":"20","author":"Wang","year":"2008","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"12","key":"10.1002\/14651858.CD006625.pub3-BIB0236|cit236","first-page":"1394","article-title":"Comparative study of efficacy and safety of quetiapine and risperidone in the treatment of elderly schizophrenia","volume":"16","author":"Wang","year":"2008","journal-title":"China Journal of Health Psychology"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0237|cit237","first-page":"33","article-title":"Comparison on the efficacy of quetiapine and risperidone in the treatment of the depressive symptom of schizophrenia","volume":"20","author":"Wang","year":"2008","journal-title":"Tianjin Pharmacy"},{"issue":"18","key":"10.1002\/14651858.CD006625.pub3-BIB0238|cit238","first-page":"61","article-title":"Effects of quetiapine on cognitive function in schizophrenia patients","volume":"3","author":"Wang","year":"2008","journal-title":"China Practical Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0239|cit239","first-page":"194","article-title":"A randomized, double blind double dummy parallel controlled study in the female first-onset schizophrenia treated with aripiprazole and quetiapine","volume":"6","author":"Wei","year":"2006","journal-title":"Nervous Diseases and Mental Health"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0240|cit240","first-page":"43","article-title":"A control study of quetiapine and clozapine in the treatment of eldly schizophrenia","volume":"16","author":"Wei","year":"2006","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"8","key":"10.1002\/14651858.CD006625.pub3-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/sj.npp.1300216","article-title":"Comparison of cognitive performances during a placebo period and an atypical antipsychotic treatment period in schizophrenia: critical examination of confounds","volume":"28","author":"Weickert","year":"2003","journal-title":"Neuropyschopharmacology"},{"issue":"22","key":"10.1002\/14651858.CD006625.pub3-BIB0242|cit242","first-page":"3089","article-title":"A control study of quetiapine and risperidone in the treatment of schizophrenia","volume":"21","author":"Wen","year":"2005","journal-title":"Modern Medicine Health"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0243|cit243","first-page":"106","article-title":"A control study of quetiapine and risperidone in the treatment of schizophrenia","volume":"15","author":"Wu","year":"2005","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0244|cit244","first-page":"40","article-title":"Treatment of 31 cases of schizophrenia with quetiapine","volume":"24","author":"Xiang","year":"2005","journal-title":"Herald of Medicine"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0245|cit245","first-page":"227","article-title":"A study of Quetiapine in treatment of schizophrenia","volume":"12","author":"Xu","year":"2002","journal-title":"Journal of Clinical Psychology Medicine"},{"issue":"9","key":"10.1002\/14651858.CD006625.pub3-BIB0246|cit246","first-page":"542","article-title":"Effects of domestic quetiapine vs clozapine in treatment of schizophrenia","volume":"7477","author":"Xu","year":"2003","journal-title":"Chinese Journal of New Drugs and Clinical Remedies"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0247|cit247","first-page":"20","article-title":"Comparison of efficacy and safety of seroquel and risperidone in the treatment of schizophrenia","volume":"9","author":"Xu","year":"2005","journal-title":"Journal of Jiangsu Clinical Medicine"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0248|cit248","first-page":"1032","article-title":"Comparative observation on the efect of quetiapine fumarate on chronic schizoprenia patients","volume":"6","author":"Xu","year":"2006","journal-title":"China Tropical Medicine"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0249|cit249","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00019442-200505000-00006","article-title":"Influence of aging on the improvement of subjective sleep quality by atypical antipsychotic drugs in patients with schizophrenia: comparison of middle-aged and older adults","volume":"13","author":"Yamashita","year":"2005","journal-title":"American Journal of Geriatric Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0250|cit250","first-page":"12","article-title":"Control study on quetiapine and clozapine in treatment of refractory schizophrenia","volume":"16","author":"Yang","year":"2004","journal-title":"Medical Journal of Chinese People Health"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0251|cit251","first-page":"159","article-title":"The effect of quetiapine and risperidone on the EEG of first-episode schizophrenic patients","volume":"18","author":"Yang","year":"2005","journal-title":"Shandong Archives of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0252|cit252","first-page":"159","article-title":"The effect of quetiapine and risperidone on the EEG of first-episode schizophrenic patients","volume":"18","author":"Yang","year":"2005","journal-title":"Shandong Archives of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0253|cit253","first-page":"276","article-title":"Control study of quetiapine and clozapine in the treatment of refractory schizophrenia","volume":"14","author":"Yang","year":"2006","journal-title":"Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease"},{"issue":"9","key":"10.1002\/14651858.CD006625.pub3-BIB0254|cit254","first-page":"1034","article-title":"A clinical study of quetiapine associated with clonazepam in the treatment of schizophrenia","volume":"27","author":"Yang","year":"2006","journal-title":"Journal of Qiqihar Medical College"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0255|cit255","first-page":"24","article-title":"Control study on using quetiapine to treat schizophrenic patients","volume":"1","author":"Yang","year":"2006","journal-title":"China Practical Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0256|cit256","first-page":"203","article-title":"Comparative study between the effect of risperidone and quetiapine in first-episode schizophrenia","volume":"19","author":"Yang","year":"2007","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0257|cit257","first-page":"29","article-title":"Comparative study of curative effects and influence on cognitive function of quetiapine and clozapine in schizophrenia","volume":"13","author":"Yang","year":"2007","journal-title":"Journal of Clinical Psychosomatic Disorders"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0258|cit258","first-page":"4","article-title":"Comparison of quetiapine and clozapine in treatment of schizophrenia","volume":"25","author":"Yu","year":"2003","journal-title":"Journal of Clinical Psychiatry Medicine"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0259|cit259","first-page":"362","article-title":"A control study of quetiapine and risperidone in the treatment of schizophrenia","volume":"15","author":"Yu","year":"2005","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0260|cit260","first-page":"298","article-title":"A control study of quetiapine and loxapine in the treatment of schizophrenia","volume":"16","author":"Yu","year":"2006","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"2B","key":"10.1002\/14651858.CD006625.pub3-BIB0261|cit261","first-page":"482","article-title":"A contrast observation of quetiapine and clozapine in affecting electroencephalogram","volume":"12","author":"Yuan","year":"2005","journal-title":"Journal of Practical Medical Techniques"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0262|cit262","first-page":"367","article-title":"A control study of quetiapine and aripiprazole in the treatment of children's schizophrenia","volume":"16","author":"Zeng","year":"2006","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0263|cit263","first-page":"262","article-title":"A comparative study between quetiapine and risperidone in the treatment of schizophrenia","volume":"11","author":"Zhang","year":"2003","journal-title":"Health Psychology Journal"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0264|cit264","first-page":"86","article-title":"A comparative study of quetiapine and clozapine in the treatment of schizophrenia","volume":"18","author":"Zhang","year":"2005","journal-title":"Shandong Archives of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0265|cit265","first-page":"91","article-title":"A comparative study of social function in schizophrenia patients treated with seroquel (quetiapine) or clozapine","volume":"18","author":"Zhang","year":"2005","journal-title":"Sichuan Mental Health"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0266|cit266","first-page":"290","article-title":"A comparative study of EKG changed by quetiapine and clozapine in the treatment of schizophrenia","volume":"17","author":"Zhang","year":"2005","journal-title":"Medical Journal of Chinese People Health"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0267|cit267","first-page":"260","article-title":"A comparative study of quetiapine combined with clomipramine in treatment of schizophrenia with obsessive-compulsive symptoms","volume":"13","author":"Zhang","year":"2005","journal-title":"Chinese Journal of Health Psychology"},{"issue":"12","key":"10.1002\/14651858.CD006625.pub3-BIB0268|cit268","first-page":"1088","article-title":"A control study of quetiapine and risperidone in the treatment of first-episode schizophrenia","volume":"3","author":"Zhang","year":"2005","journal-title":"Chinese Journal of Current Traditional and Western Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0269|cit269","first-page":"81","article-title":"Comparison study on treatment of primary schizophrenia with quetiapine and chlorpromazine","volume":"30","author":"Zhang","year":"2006","journal-title":"Heilongjiang Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0270|cit270","first-page":"300","article-title":"A control study of quetiapine and clozapine in the treatment of schizophrenia","volume":"16","author":"Zhang","year":"2006","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0271|cit271","first-page":"197","article-title":"A control study of quetiapine and risperidone in the treatment of schizophrenia","volume":"17","author":"Zhang","year":"2007","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0272|cit272","first-page":"97","article-title":"A comparative study of quetiapine and chlorpromazine in the treatment of schizophrenia","volume":"9","author":"Zhang","year":"2007","journal-title":"Modern Medicine Journal of China"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0273|cit273","unstructured":"Zhang B Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (SeroquelIR) in Controlling Agitation and AggressiveSymptoms in the Acute Treatment of Patients With Schizophrenia WHO trial registration 2009"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0274|cit274","first-page":"25","article-title":"Control studies of quetiapine and risperidone in the treatment of schizophrenia","volume":"10","author":"Zhao","year":"2004","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0275|cit275","first-page":"56, 79-80","article-title":"Control study of quetiapine and risperidone in treatment of schizophrenics","volume":"13","author":"Zhao","year":"2005","journal-title":"Heath Psychology Journal"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0276|cit276","first-page":"231","article-title":"A study of quetiapine and clozapine in treatment of schizophrenia","volume":"15","author":"Zhao","year":"2005","journal-title":"Journal of Clinical Psychology Medicine"},{"issue":"7","key":"10.1002\/14651858.CD006625.pub3-BIB0277|cit277","first-page":"1181","article-title":"A study of low-dos equetiapine with sulpiride in the treatment of schizophrenia","volume":"24","author":"Zhao","year":"2007","journal-title":"Journal of Clinical Research"},{"issue":"23","key":"10.1002\/14651858.CD006625.pub3-BIB0278|cit278","first-page":"1878","article-title":"A control study of quetiapine and clozapine in the treatment of schizophrenia","volume":"13","author":"Zheng","year":"2007","journal-title":"Medical Recapitulate"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0279|cit279","first-page":"30","article-title":"Effect of antipsychotic plus buflomedil hydrochlorde in ameliorating the negative symptoms of patients with schizophrenia","volume":"10","author":"Zhong","year":"2006","journal-title":"Zhongguo Linchuang Kangfu"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0280|cit280","first-page":"395","article-title":"A control of treating chronic schizophrenia with seroquel or clozapine","volume":"38","author":"Zhou","year":"2003","journal-title":"Jiangxi Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0281|cit281","first-page":"215","article-title":"A comparative study of quetiapine and clozapine in the treatment of patients with schizophrenia","volume":"15","author":"Zhou","year":"2003","journal-title":"Shanghai Archives of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD006625.pub3-BIB0282|cit282","first-page":"368","article-title":"A study of quetiapine with sulpiride in the treatment of chronic schizophrenia","volume":"16","author":"Zhou","year":"2006","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006625.pub3-BIB0283|cit283","first-page":"261","article-title":"A control study of quetiapine and risperidone in the treatment of schizophrenia","volume":"23","author":"Zhou","year":"2007","journal-title":"Journal of Baotou Medical College"},{"issue":"8","key":"10.1002\/14651858.CD006625.pub3-BIB0284|cit284","first-page":"792","article-title":"A control study of quetiapine and clozapine in the treatment of female schizophrenia","volume":"25","author":"Zhu","year":"2006","journal-title":"Herald of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0285|cit285","first-page":"9","article-title":"A control study of quetiapine and aripiprozole in the treatment of schizophrenia","volume":"8","author":"Zhu","year":"2008","journal-title":"Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0286|cit286","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/JCP.0b013e3181f198da","article-title":"Efficacy and adverse effects of quetiapine versus risperidone in first-episode schizophrenia","volume":"30","author":"Gafoor","year":"2010","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0287|cit287","first-page":"S509","article-title":"A comparative study of quetiapine and risperidone in patients with first-episode psychosis","volume":"15(Suppl 3)","author":"Gafoor","year":"2005","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0288|cit288","unstructured":"Eli Lilly Company Comparison of continuing olanzapine to switching to quetiapine in overweight or obese patients with schizophrenia and schizoaffective disorder Eli Lilly and Company Clinical Trial Registry 2004"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0289|cit289","unstructured":"Li HF A 6-Week, Multicenter, Rater-Blind, Randomized,Risperidone-Controlled Study to Evaluate the Efficacy and Safety of Seroquel (Quetiapine Fumarate) in the Treatment of Chinese Han Patients With Schizophrenia WHO registration 2009"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0290|cit290","unstructured":"Ratna L A multi-centre, double-blind, randomised study to compare the safety tolerability and efficacy of quetiapine and risperidone in the treatment of schizophrenia in subjects with inadequate symptom control improved Response In Schizophrenia - IRIS National Research Register 2003"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0291|cit291","unstructured":"Reynolds C A six month, rater blind comparison of quetiapine and risperidone in the treatment of tardive dyskinesia in patients with schizophrenia National Research Register 2001"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0292|cit292","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0447.1986.tb06225.x","article-title":"Suicide and violent death among patients with schizophrenia","volume":"74","author":"Allebeck","year":"1986","journal-title":"Acta Psychiatrica Scandinavia"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0293|cit293","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecing skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0294|cit294","unstructured":"Andreasen NC Scale for the assessment of positive symptoms (SAPS) The University of Iowa 1984"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0295|cit295","first-page":"53","article-title":"Scale for the assessment of negative symptoms (SANS)","volume":"7","author":"Andreasen","year":"1989","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0296|cit296","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/schbul\/17.3.475","article-title":"Assessment issues and the cost of schizophrenia","volume":"17","author":"Andreasen","year":"1991","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0297|cit297","first-page":"1","article-title":"Practice guidelines for the treatment of patients with schizophrenia","volume-title":"American Journal of Psychiatry","author":"American Psychiatric Association","year":"2004"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0298|cit298","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","article-title":"Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence","volume":"18","author":"Arnt","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0299|cit299","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0300|cit300","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD006625.pub3-BIB0301|cit301","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0302|cit302","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/schbul\/10.3.388","article-title":"The quality of life scale: an instrument for rating the schizophrenic deficit syndrom","volume":"10","author":"Heinrichs","year":"1984","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0303|cit303","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM199403103301006","article-title":"Schizophrenia","volume":"330","author":"Carpenter","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0304|cit304","first-page":"233","article-title":"The extrapyramidal symptom rating scale","volume":"7","author":"Chouinard","year":"1980","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0305|cit305","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Proceedings of the 8th International Cochrane Colloquium, Cape Town, South Africa, October 25-28, 2000"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0306|cit306","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0307|cit307","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0308|cit308","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0309|cit309","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001359.pub2","article-title":"Olanzapine for schizophrenia","author":"Duggan","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0310|cit310","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"13","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0311|cit311","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004578.pub3","article-title":"Aripiprazole for schizophrenia","author":"El-Sayeh","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0312|cit312","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0313|cit313","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0314|cit314","unstructured":"Gaebel W Falkai P Weinmann S Wobrock T Treatment guidelines for schizophrenia Steinkopf 2006"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0315|cit315","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF02244924","article-title":"Seroquel: electrophysiological profile of a potential atypical antipsychotic","volume":"112","author":"Goldstein","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0316|cit316","first-page":"95","article-title":"Preclinical tests that predict clozapine-like atypical antipsychotic actions","volume":"10","author":"Goldstein","year":"1995","journal-title":"Critical issues in the treatment of schizophrenia. International Academy of biochemical Drug Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0317|cit317","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0318|cit318","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0319|cit319","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1176\/appi.ajp.163.2.185","article-title":"Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine","volume":"163","author":"Heres","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0320|cit320","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0321|cit321","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions 5.0.1 [updated September 2008] The Cochrane Collaboration, 2008 www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0322|cit322","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011 www.cochrane-handbook.org."},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0323|cit323","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2141.2009.07707.x","article-title":"Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials","volume":"146","author":"Hutton","year":"2009","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0324|cit324","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on quality of life","volume":"63","author":"Jones","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0325|cit325","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment of treatment-resistant schizophrenia: a double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0326|cit326","first-page":"585","article-title":"Treatment programme and long term outcome in chronic schizophrenia","volume":"46","author":"Kane","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0327|cit327","volume-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0328|cit328","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0329|cit329","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of Brief Psychiatric Rating Scale Scores (BPRSS)","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0330|cit330","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Liebermann","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0331|cit331","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales - a major source of bias in randomised controlled trials of treatments for schizophrenia?","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0332|cit332","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00127-004-0762-4","article-title":"Schizophrenia and employment - a review","volume":"39","author":"Marvaha","year":"2004","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0333|cit333","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF02244925","article-title":"Seroquel: behavioral profile of a potential atypical antipsychotic","volume":"112","author":"Migler","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0334|cit334","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: Revised recommendations for improving the quality of reports of parallel group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0335|cit335","first-page":"329","article-title":"New assessment of atypical antipsychotics","volume":"71","author":"Moller","year":"2000","journal-title":"Nervenarzt"},{"issue":"9426","key":"10.1002\/14651858.CD006625.pub3-BIB0336|cit336","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(04)16458-1","article-title":"Schizophrenia","volume":"363","author":"Mueser","year":"2004","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0337|cit337","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0338|cit338","volume-title":"Modern Psychometrics","author":"Rust","year":"1989"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0339|cit339","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02244923","article-title":"Seroquel: biochemical profile of a potential atypical antipsychotic","volume":"112","author":"Saller","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0340|cit340","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/9780470712184.ch12","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2008"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0341|cit341","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side-effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"2","key":"10.1002\/14651858.CD006625.pub3-BIB0342|cit342","article-title":"Quetiapine for schizophrenia","author":"Srisurapanont","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0343|cit343","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jclinepi.2008.12.011","article-title":"A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers","volume":"62","author":"Thorpe","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD006625.pub3-BIB0344|cit344","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0345|cit345","unstructured":"Xia J Adams CE Bhagat N Bhagat V Bhoopathi P El-Sayeh H The Leeds Outcomes Stakeholders Survey (LOSS) study Proceedings of the 15th Cochrane Colloquium, Sao Paulo, October 23-27, 2007"},{"issue":"1","key":"10.1002\/14651858.CD006625.pub3-BIB0346|cit346","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006626.pub2","article-title":"Quetiapine versus other atypical antipsychotics for schizophrenia","author":"Komossa","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006625.pub3-BIB0347|cit347","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1176\/appi.ajp.2008.08030368","article-title":"A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia","volume":"166","author":"Leucht","year":"2009","journal-title":"American Journal of Psychiatry"},{"issue":"Issue 2","key":"10.1002\/14651858.CD006625.pub3-BIB0348|cit348","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000967.pub2","article-title":"Quetiapine for schizophrenia","author":"Srisurapanont","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006625.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T21:12:43Z","timestamp":1746047563000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006625.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,18]]},"references-count":348,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006625.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,18]]}}}